SK58198A3 - Treatment of traumatic brain injury - Google Patents
Treatment of traumatic brain injury Download PDFInfo
- Publication number
- SK58198A3 SK58198A3 SK581-98A SK58198A SK58198A3 SK 58198 A3 SK58198 A3 SK 58198A3 SK 58198 A SK58198 A SK 58198A SK 58198 A3 SK58198 A3 SK 58198A3
- Authority
- SK
- Slovakia
- Prior art keywords
- tetrazol
- tetrahydro
- ethyl
- methylpyridine
- injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK123295 | 1995-11-06 | ||
PCT/DK1996/000458 WO1997017074A1 (en) | 1995-11-06 | 1996-11-05 | Treatment of traumatic brain injury |
Publications (1)
Publication Number | Publication Date |
---|---|
SK58198A3 true SK58198A3 (en) | 1998-10-07 |
Family
ID=8102484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK581-98A SK58198A3 (en) | 1995-11-06 | 1996-11-05 | Treatment of traumatic brain injury |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0866706A1 (de) |
JP (1) | JPH11514654A (de) |
KR (1) | KR19990067353A (de) |
AU (1) | AU706594B2 (de) |
BG (1) | BG63150B1 (de) |
BR (1) | BR9611396A (de) |
CA (1) | CA2234824A1 (de) |
CZ (1) | CZ287441B6 (de) |
EA (1) | EA000531B1 (de) |
HU (1) | HUP9901051A2 (de) |
IS (1) | IS4726A (de) |
NO (1) | NO982036L (de) |
NZ (1) | NZ321546A (de) |
PL (1) | PL326490A1 (de) |
SK (1) | SK58198A3 (de) |
TR (1) | TR199800801T2 (de) |
WO (1) | WO1997017074A1 (de) |
ZA (1) | ZA969320B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013096A1 (es) * | 1997-07-01 | 2000-12-13 | Lundbeck & Co As H | Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma. |
EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2377530A3 (de) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation von Neurogenese durch PDE-Hemmung |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (de) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenese mittels Angiotensin-Modulation |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
US5328925A (en) * | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
IE922270A1 (en) * | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
US5330994A (en) * | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
-
1996
- 1996-11-05 CA CA002234824A patent/CA2234824A1/en not_active Abandoned
- 1996-11-05 BR BR9611396A patent/BR9611396A/pt not_active Application Discontinuation
- 1996-11-05 JP JP9517762A patent/JPH11514654A/ja active Pending
- 1996-11-05 NZ NZ321546A patent/NZ321546A/xx unknown
- 1996-11-05 EA EA199800434A patent/EA000531B1/ru not_active IP Right Cessation
- 1996-11-05 TR TR1998/00801T patent/TR199800801T2/xx unknown
- 1996-11-05 AU AU74900/96A patent/AU706594B2/en not_active Ceased
- 1996-11-05 WO PCT/DK1996/000458 patent/WO1997017074A1/en not_active Application Discontinuation
- 1996-11-05 HU HU9901051A patent/HUP9901051A2/hu unknown
- 1996-11-05 EP EP96937193A patent/EP0866706A1/de not_active Ceased
- 1996-11-05 CZ CZ19981389A patent/CZ287441B6/cs not_active IP Right Cessation
- 1996-11-05 SK SK581-98A patent/SK58198A3/sk unknown
- 1996-11-05 PL PL96326490A patent/PL326490A1/xx unknown
- 1996-11-05 KR KR1019980703360A patent/KR19990067353A/ko not_active Application Discontinuation
- 1996-11-06 ZA ZA969320A patent/ZA969320B/xx unknown
-
1998
- 1998-04-27 IS IS4726A patent/IS4726A/is unknown
- 1998-05-05 NO NO982036A patent/NO982036L/no not_active Application Discontinuation
- 1998-05-22 BG BG102480A patent/BG63150B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
BG63150B1 (bg) | 2001-05-31 |
AU7490096A (en) | 1997-05-29 |
AU706594B2 (en) | 1999-06-17 |
NO982036L (no) | 1998-06-25 |
MX9803432A (es) | 1998-09-30 |
WO1997017074A1 (en) | 1997-05-15 |
BG102480A (en) | 1999-01-29 |
HUP9901051A2 (hu) | 2000-03-28 |
PL326490A1 (en) | 1998-09-28 |
ZA969320B (en) | 1997-05-30 |
CZ138998A3 (cs) | 1998-10-14 |
EP0866706A1 (de) | 1998-09-30 |
CA2234824A1 (en) | 1997-05-15 |
KR19990067353A (ko) | 1999-08-16 |
JPH11514654A (ja) | 1999-12-14 |
NO982036D0 (no) | 1998-05-05 |
BR9611396A (pt) | 1999-07-13 |
EA199800434A1 (ru) | 1998-10-29 |
TR199800801T2 (xx) | 1998-08-21 |
CZ287441B6 (en) | 2000-11-15 |
IS4726A (is) | 1998-04-27 |
EA000531B1 (ru) | 1999-10-28 |
NZ321546A (en) | 2000-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69631134T2 (de) | Verfahren zur bekämpfung infektiöser krankheiten unter verwendung dikationischer bis-benzimidazole | |
JP2020128384A (ja) | 医薬溶液、調製方法及び治療的使用 | |
EP2040548B1 (de) | Verfahren zur behandlung neurologischer erkrankungen mittels verstärkung der beta -glucocerebrosidaseaktivität | |
DE69718731T2 (de) | Kombinationstherapie für die Behandlung von Psychosen | |
DE69834508T2 (de) | Apoptoseinhibitoren | |
DE69932154T2 (de) | Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen | |
JP2018519358A (ja) | 神経変性疾患を処置する方法 | |
SK4862000A3 (en) | The use of 5-ht3 receptor antagonists | |
US6297262B1 (en) | Treatment of schizophrenia and psychosis | |
SK58198A3 (en) | Treatment of traumatic brain injury | |
DE69432474T2 (de) | Verwendung von 2-(2aklylphenylamino)oxazolinen und-thiazolinen zur herstellung eines medikaments mit alpha 2 adrenergener wirkung | |
JP2010533166A (ja) | シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤 | |
KR20020001850A (ko) | 기분장애, 적응장애 또는 혼재성 불안우울증의 치료 또는예방에 사용되는 의약의 제조를 위한 사레듀턴트 및 그의제약상 허용되는 염의 용도 | |
EP0278467B1 (de) | Verwendung von Oxochinazolinderivaten bei der Behandlung von Hyperurikämie | |
US4305942A (en) | Xanthine oxidase inhibitor and therapeutic treatment using same | |
EP0538248B1 (de) | Tetrahydroisochinolinylcarbamate von 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo [2,3-b] indol | |
US20070191400A1 (en) | Pharmaceutical compositions comprising anti-inflammatory quinazolinecarboxamide derivatives | |
US20210332042A1 (en) | A GABAA Receptor Ligand | |
DE3904795C2 (de) | Pharmazeutisches Präparat und dessen Verwendung | |
US20230165852A1 (en) | Method for treating central nervous system disorders using dopamine d3 partial agonists | |
CA2541045A1 (en) | A descarbonylethoxyloratadine containing pharmaceutical composition | |
MXPA98003432A (en) | Treatment of traumat cerebral damage | |
US20050054667A1 (en) | Method of treating or inhibiting anti-arrhythmic events in male human patients | |
CN117396202A (zh) | 给药方案 | |
TW202328165A (zh) | 硫鏈絲菌肽組合物及其製備 |